Nivo/Ipi Combination Therapy in Symptomatic Brain Metastases

NCT02621515 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
7
Enrollment
OTHER
Sponsor class

Stopped In the Netherlands we wanted to add pilimumab to nivolumab. This resulted in a very long METC procedure which resulted in a to slow inclusion rate.

Conditions

Interventions

Sponsor

University Medical Center Groningen